TNF-α −308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment-Reference-Cited by-全球学者库

TNF-α −308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment

Published:2011-10 Issue:3 Volume:504 Page:277-280
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Huang Hsiang-Hsuan,Wang Ying-Chieh,Wu Chia-Liang,Hong Chen-Jee,Bai Ya-Mei,Tsai Shih-Jen,Liou Ying-Jay

Publisher

Elsevier BV

Subject

General Neuroscience

Reference28 articles.

1. Impact of the −308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease;Abraham;J. Leukoc. Biol.,1999

2. Antipsychotic-induced weight gain: a comprehensive research synthesis;Allison;Am. J. Psychiatry,1999

3. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle;Basile;J. Clin. Psychiatry,2001

4. Tumor necrosis factor-alpha −308 G/A polymorphism in obese Caucasians;Brand;Int. J. Obes. Relat. Metab. Disord.,2001

5. Differential effect of clozapine on weight: a controlled study;Bustillo;Am. J. Psychiatry,1996

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics of Medication‐Induced Weight Gain and Antiobesity Medications;Obesity;2021-01-24

2. Pharmacogenetic Correlates of Antipsychotic-Induced Weight Gain in the Chinese Population;Neuroscience Bulletin;2019-01-03

3. Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics;Pharmacogenomics and Personalized Medicine;2016-11

4. Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis;Schizophrenia Bulletin;2016-05-23

5. Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management;Acta Psychiatrica Scandinavica;2015-05-27